Injury to tissue caused by device penetration of the skin triggers formation of extracellular traps
Year: 2025
Type: article
Abstract: Continuous glucose monitoring (CGM) systems are vital for diabetes management, but sensor performance is often compromised by host immune responses following insertion. This study investigates early tissue and immune reactions, focusing on neutrophil extracellular trap (NET) formation, or NETosis. In porcine models, insertion trauma rapidly induced NETosis, preceding vascular regression and fibrotic encapsulation—processes that may hinder glucose diffusion and impair sensor accuracy. In a murine air pouch model, sensor implantation elevated inflammatory cytokines (IL-6, KC/GRO) and neutrophil infiltration within 24 hours. Scanning electron microscopy revealed NETs exclusively in traumatized tissue. Notably, neutrophils from type 2 diabetes patients failed to undergo NETosis on polyurethane surfaces in vitro, suggesting impaired immune responses due to metabolic dysfunction. These findings identify NETosis as a key driver of early sensor-tissue interactions. Strategies to reduce insertion trauma and modulate NET formation may enhance CGM reliability and longevity, informing future improvements in sensor design and deployment. Insertion trauma triggers NETosis and acute inflammation, impairing CGM performance. Neutrophils from T2D patients fail to form NETs on sensors, suggesting metabolic dysfunction. Targeting NETs may enhance sensor integration and extend device lifespan.
Source: Communications Biology
Authors: Kenneth A. Wood, Priscila S. Cunegundes, Jean G. de Souza, Joseph Cavataio, Tejas Kakunje, Don L. Kreutzer, Ulrike Klueh
Institutions: Wayne State University, University of Connecticut, UConn Health
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $4,190
Awards: G1283301421, A novel inline platform provides an advanced drug delivery device foroptimized diabetes therapy, G5565660095, Infusion device optimization by addressing root causes of the inflammatory response, G6564610076, G6676290494, Michigan Diabetes Research Center (MDRC), CANCER CENTER SUPPORT GRANT
OpenAlex ID: W4416668030
